Abstract
T-cell prolymphocytic leukemia (T-PLL) is a rare type of peripheral T-cell leukemia. In this study, we examined the clinical and biological characteristics of 11 Japanese patients with T-PLL. Median age was 74 years, with male predominance. Median lymphocyte frequency was 85.3% in blood. Physical characteristics were splenomegaly (36.4%), tiny lymph adenopathy (63.6%), skin lesion (9.1%) and pleural effusion (27.3%). Median survival was 30.1 months, despite treatment with various chemotherapeutic modalities. Although complex chromosomal abnormalities were observed in 5 of 11 cases (45.5%), typical 14q32 and Xq28 abnormalities were not detected. TCL1A mRNA expression was observed in 6 of 11 cases (54.5%) on real-time quantitative PCR. In 5 of these 6 cases, flow cytometric analysis and/or immunohistochemistry confirmed the expression of TCLA1 protein. Split signals for the TCL1 region on fluorescence in situ hybridization confirmed rearrangement in 3 out of 7 cases evaluated. These cases corresponded to cases that were positive for TCL1A expression, suggesting that rearrangement of the TCL1 region induced high expression of TCL1A gene. In summary, a substantial number of T-PLL cases in Japan had abnormal expression of TCL1A, probably due to rearrangement of TCL1 region. Expression and/or rearrangement of TCL1A may, therefore, be a useful marker for diagnosing T-PLL, regardless of chromosomal abnormalities.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12185-011-0986-5/MediaObjects/12185_2011_986_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12185-011-0986-5/MediaObjects/12185_2011_986_Fig2_HTML.gif)
Similar content being viewed by others
References
Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. 1991;78:3269–74.
Hoyer JD, Ross CW, Li CY, Witzig TE, Gascoyne RD, Dewald GW, et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood. 1995;86:1163–9.
Garand R, Goasguen J, Brizard A, Buisine J, Charpentier A, Claisse JF, et al. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais d’Hematologie Cellulaire. Br J Haematol. 1998;103:488–94.
Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104:328–35.
Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood. 2008;111:328–37.
Dearden CE, Matutes E, Cazin B, Tjonnfjord GE, Parreira A, Nomdedeu B, et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 2001;98:1721–6.
Keating MJ, Cazin B, Coutre S, Birhiray R, Kovacsovics T, Langer W, et al. Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed. J Clin Oncol. 2002;20:205–13.
Krishnan B, Else M, Tjonnfjord GE, Cazin B, Carney D, Carter J, et al. Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study. Br J Haematol. 2010;149:907–10.
Brito-Babapulle V, Pomfret M, Matutes E, Catovsky D. Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia. Blood. 1987;70:926–31.
Heinonen K, Mahlamaki E, Hamalainen E, Nousiainen T, Mononen I. Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia. Cancer Genet Cytogenet. 1994;78:28–35.
Mossafa H, Brizard A, Huret JL, Brizard F, Lessard M, Guilhot F, et al. Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T-prolymphocytic leukaemia: four new cases and a review of the literature. Br J Haematol. 1994;86:780–5.
Maljaei SH, Brito-Babapulle V, Hiorns LR, Catovsky D. Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization. Cancer Genet Cytogenet. 1998;103:110–6.
Virgilio L, Lazzeri C, Bichi R, Nibu K, Narducci MG, Russo G, et al. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci USA. 1998;95:3885–9.
Pekarsky Y, Hallas C, Croce CM. Molecular basis of mature T-cell leukemia. JAMA. 2001;286:2308–14.
Gritti C, Dastot H, Soulier J, Janin A, Daniel MT, Madani A, et al. Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood. 1998;92:368–73.
Laine J, Kunstle G, Obata T, Noguchi M. Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. J Biol Chem. 2002;277:3743–51.
Narducci MG, Pescarmona E, Lazzeri C, Signoretti S, Lavinia AM, Remotti D, et al. Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. Cancer Res. 2000;60:2095–100.
Saitou M, Sugimoto J, Hatakeyama T, Russo G, Isobe M. Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene. 2000;19:2796–802.
Teitell MA. The TCL1 family of oncoproteins: co-activators of transformation. Nat Rev Cancer. 2005;5:640–8.
De Schouwer PJ, Dyer MJ, Brito-Babapulle VB, Matutes E, Catovsky D, Yuille MR. T-cell prolymphocytic leukaemia: antigen receptor gene rearrangement and a novel mode of MTCP1 B1 activation. Br J Haematol. 2000;110:831–8.
Kojima K, Kobayashi H, Imoto S, Nakagawa T, Matsui T, Kawachi Y, et al. 14q11 abnormality and trisomy 8q are not common in Japanese T-cell prolymphocytic leukemia. Int J Hematol. 1998;68:291–6.
Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol. 2008;80:469–76.
Satou Y, Yasunaga J, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA. 2006;103:720–5.
Chun HH, Castellvi-Bel S, Wang Z, Nagourney RA, Plaeger S, Becker-Catania SG, et al. TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxia-telangiectasia. Int J Cancer. 2002;97:726–31.
Yokohama A, Karasawa M, Takada S, Matsushima T, Murakami H, Miyao S, et al. Prolonged survival in two cases of T-prolymphocytic leukemias with complex hypodiploid chromosomal abnormalities. J Med. 2000;31:183–94.
Shichishima T, Kawaguchi M, MacHii T, Matsuoka R, Ogawa K, Maruyama Y. T-prolymphocytic leukaemia with spontaneous remission. Br J Haematol. 2000;108:397–9.
Miyata A, Kojima K, Yoshino T, Fujii S, Shinagawa K, Ichimura K. Concurrent Hodgkin’s disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia. Int J Hematol. 2001;73:230–5.
Sugimoto T, Imoto S, Matsuo Y, Kojima K, Yasukawa M, Murayama T, et al. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype. Ann Hematol. 2001;80:749–51.
Tamayose K, Sato N, Ando J, Sugimoto K, Oshimi K. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature. Am J Hematol. 2002;71:331–5.
Toyota S, Nakamura N, Dan K. T-cell prolymphocytic leukemia with hemorrhagic gastrointestinal involvement and a new chromosomal abnormality. Int J Hematol. 2002;75:314–7.
Murase K, Matsunaga T, Sato T, Kuribayashi K, Kogawa K, Kawano Y, et al. Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. Int J Clin Oncol. 2003;8:391–4.
Yamaguchi M, Yamamoto K, Miki T, Mizutani S, Miura O. T-cell prolymphocytic leukemia with der(11)t(1;11)(q21;q23) and ATM deficiency. Cancer Genet Cytogenet. 2003;146:22–6.
Toyota S, Nakamura N, Dan K. Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype. Int J Hematol. 2005;81:66–8.
Ogasawara T, Narita C, Kawauchi K. Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia. Leuk Res. 2007;31:403–6.
Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, et al. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia. 2005;19:201–8.
Pekarsky Y, Hallas C, Isobe M, Russo G, Croce CM. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci USA. 1999;96:2949–51.
Acknowledgments
We are grateful to professor Masayuki Noguchi (Hokkaido University), who kindly provided experimental materials.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yokohama, A., Saitoh, A., Nakahashi, H. et al. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients. Int J Hematol 95, 77–85 (2012). https://doi.org/10.1007/s12185-011-0986-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-011-0986-5